Flagship explainer
What drives Bolt Biotherapeutics, Inc.’s return on equity?
ROE is five filed business factors multiplied together.
| Input | Value | Fiscal year | Source |
|---|---|---|---|
| −$33.4M | FY2025 |
| |
| Income before tax | −$33.4M | FY2025 |
|
| Operating income | −$36.1M | FY2025 |
|
| $7.7M | FY2025 |
| |
| Ending assets | $56.7M | FY2025 |
|
| Beginning assets | $99.6M | FY2024 |
|
| $26.5M | FY2025 |
| |
| $57.2M | FY2024 |
|
Source:
- SEC filingFiling detailsAccession 0001193125-26-104121